坏死性下垂
免疫原性
免疫原性细胞死亡
程序性细胞死亡
癌细胞
细胞凋亡
癌症研究
医学
生物
免疫学
免疫疗法
免疫系统
癌症
肿瘤微环境
遗传学
生物化学
作者
Robin Demuynck,Iuliia Efimova,Faye Naessens,Dmitri V. Krysko
标识
DOI:10.1136/jitc-2021-003430
摘要
Ferroptosis is a recently discovered form of regulated cell death that is morphologically, genetically, and biochemically distinct from apoptosis and necroptosis, and its potential use in anticancer therapy is emerging. The strong immunogenicity of (early) ferroptotic cancer cells broadens the current concept of immunogenic cell death and opens up new possibilities for cancer treatment. In particular, induction of immunogenic ferroptosis could be beneficial for patients with cancers resistant to apoptosis and necroptosis. However, ferroptotic cancer cells may be a rich source of oxidized lipids, which contribute to decreased phagocytosis and antigen cross-presentation by dendritic cells and thus may favor tumor evasion. This could explain the non-immunogenicity of late ferroptotic cells. Besides the presence of lactate in the tumor microenvironment, acidification and hypoxia are essential factors promoting ferroptosis resistance and affecting its immunogenicity. Here, we critically discuss the crucial mediators controlling the immunogenicity of ferroptosis that modulate the induction of antitumor immunity. We emphasize that it will be necessary to also identify the tolerogenic (ie, immunosuppressive) nature of ferroptosis, which can lead to tumor evasion.
科研通智能强力驱动
Strongly Powered by AbleSci AI